Wegovy (semaglutide injection, 2.4 mg) is FDA-approved for chronic weight management in adults with obesity, or overweight adults with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
Book an oral semaglutide consultation at Vitality Womens Healthcare in Gainesville, TX today!
Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network
Cardillo C, Kilcoyne CM, Cannon III RO, Quyyumi AA, Panza JA
Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F
NSAIDs like ibuprofen can impair renal function, especially in dehydrated states, potentially leading to acute kidney injury
